Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus

Lupus. 2012 Dec;21(14):1571-4. doi: 10.1177/0961203312463621.

Abstract

We present a case of a pregnant woman at 27 weeks of gestation with systemic lupus erythematosus who developed severe thrombocytopenia presenting with melena, epistaxis, gum bleeding and frank hematuria. She was resistant to most treatment modalities, including steroids, intravenous immunoglobulins (IVIG), rituximab, IV cyclophosphamide and eltrombopag. She responded to romiplostim with normalization of her platelet count, which enabled her to be delivered safely at 34 weeks of gestation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Platelet Count
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / physiopathology
  • Pregnancy Outcome
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Severity of Illness Index
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology
  • Thrombocytopenia / physiopathology
  • Thrombopoietin / therapeutic use*
  • Treatment Outcome

Substances

  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim